The IL-33 Receptor/ST2 acts as a positive regulator of functional mouse bone marrow hematopoietic stem and progenitor cells
Open Access
- 5 May 2020
- journal article
- research article
- Published by Elsevier in Blood Cells, Molecules, and Diseases
- Vol. 84, 102435
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
This publication has 13 references indexed in Scilit:
- The role of the IL-33/ST2 axis in autoimmune disorders: Friend or foe?Cytokine & Growth Factor Reviews, 2019
- Long-Acting IL-33 Mobilizes High-Quality Hematopoietic Stem and Progenitor Cells More Efficiently Than Granulocyte Colony-Stimulating Factor or AMD3100Transplantation and Cellular Therapy, 2019
- Phorbol ester induced ex vivo expansion of rigorously-defined phenotypic but not functional human cord blood hematopoietic stem cells: a cautionary tale demonstrating that phenotype does not always recapitulate stem cell functionLeukemia, 2019
- IL33: Roles in Allergic Inflammation and Therapeutic PerspectivesFrontiers in Immunology, 2019
- Biomarker Panel for Chronic Graft-Versus-Host DiseaseJournal of Clinical Oncology, 2016
- IL-33 signaling contributes to the pathogenesis of myeloproliferative neoplasmsJournal of Clinical Investigation, 2015
- ST2 as a Marker for Risk of Therapy-Resistant Graft-versus-Host Disease and DeathNew England Journal of Medicine, 2013
- Dipeptidylpeptidase 4 negatively regulates colony-stimulating factor activity and stress hematopoiesisNature Medicine, 2012
- T1/St2-Deficient Mice Demonstrate the Importance of T1/St2 in Developing Primary T Helper Cell Type 2 ResponsesJournal of Experimental Medicine, 2000
- In vitro behavior of hematopoietic progenitor cells under the influence of chemoattractants: stromal cell-derived factor-1, steel factor, and the bone marrow environment.1998